N.J. Admin. Code § 8:111-6.5

Current through Register Vol. 56, No. 11, June 3, 2024

Section 8:111-6.5 - Use of restraints

(a) Pharmacological restraints shall only be used in a facility licensed by the Department to provide medical detoxification services. No other types of restraints (for example, physical or medical devices) are permitted in Department-licensed substance use disorders treatment facilities.

1. The facility shall develop and implement written policies and procedures regarding pharmacological restraint use including, but not limited to:

i. Use on clients posing a threat or harm to self or others, and after other less restrictive methods have been utilized and documented in the client record and medical record as such;

ii. Specification of the circumstances in which pharmacological restraints are permitted;

iii. Specification of the frequency with which a client shall be monitored by licensed medical or nursing personnel (for example, licensed practical nurse, registered nurse, physician's assistant, physician);

iv. Specification of the documentation required in the client record and medical record describing client's reaction and behavior while on pharmacological restraint;

v. Protocols for notifying the facility's medical director or facility's physician when a pharmacological restraint is not effective and must be re-administered;

vi. A requirement that specifies a pharmacological restraint be administered only when authorized in writing by the facility's medical director or designee; and

vii. Requirement that medical and nursing staff responsible for administering pharmacological restraints have been trained and are competent to administer pharmacological restraints.

(b) The results achieved through administering a pharmacological restraint shall be documented in the client's clinical record and medical record by the facility's medical director and director of nursing and reviewed by the treatment team.

(c) Any serious incident (for example, client or staff injury or death) occurring as a result of administering a pharmacological restraint shall be reported immediately to the medical director, the administrator, the governing authority, the Department, and the police.

N.J. Admin. Code § 8:111-6.5

Amended and recodified from 10:161A-6.5 53 N.J.R. 2208(a), effective 12/20/2021